HideChilds = False
SystemName =
 

Bioverativ is proud to support the CDC Foundation to collaborate with the U.S. Centers for Disease Control and Prevention’s (CDC) Division of Blood Disorders in the development and operation of a longitudinal sickle cell disease health surveillance data

Collaborating to advance care

Sickle Cell Disease

Sickle cell disease is estimated to affect more than 5,000 Australians* and more than 18 million people worldwide. As we work to advance new and innovative therapies for sickle cell disease, we are also committed to having a positive impact on people and families living with sickle cell disease by advancing access to the information and resources needed to receive high-quality care.  

Learn more about Bioverativ’s pipeline programmes for sickle cell disease.

*Reference: Extrapolated prevalence. www.cureresearch.com/s/sickle_cell_anemia/stats-country.html  Accessed 19/10/2107